SCHEMBL328548

SCHEMBL328548

CN(C)S(=O)(=O)N(C)CCN(CC(N)=O)S(=O)(=O)c1cc(F)c(Oc2ccc(Cl)cc2)c(F)c1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DAGLA Q9Y4D2 3/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
POLB P06746 1/20 0.33
HPGD P15428 1/20 0.33
BMP1 P13497 1/20 0.33
THRB P10828 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.32
PGR P06401 1/20 0.32
MAPT P10636 1/20 0.32
HSD17B10 Q99714 1/20 0.32
SLC9A3 P48764 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL328414 0.91 DAGLA (0.37) DAGLACA12CA1CA9KMT2A
SCHEMBL328661 0.90 KMT2A (0.38) DAGLACA12CA1CA9KMT2A
SCHEMBL6864397 0.89 MMP1 (0.44) CA9KMT2ABMP1
SCHEMBL328544 0.88 DAGLA (0.35) DAGLACA12CA1CA9KMT2A
SCHEMBL6850664 0.86 DAGLA (0.43) DAGLAALDH1A1L3MBTL1POLBHPGD
SCHEMBL6850484 0.86 DAGLA (0.36) DAGLAKMT2AALDH1A1L3MBTL1POLB
SCHEMBL10066710 0.84 LSS (0.41) DAGLACA12CA1CA9KMT2A
SCHEMBL6852280 0.84 BDKRB1 (0.40) DAGLACA12CA1CA9KMT2A
SCHEMBL328643 0.83 KMT2A (0.35) DAGLAKMT2AALDH1A1POLBCYP3A4
SCHEMBL6850244 0.82 EDNRA (0.39) DAGLAL3MBTL1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2428509-A1 Human adam-10 inhibitors Symphony Evolution, Inc. (US) 2012-03-14 EP disclosed
WO-2011011181-A1 PHARMACOLOGICAL CHAPERONES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AMICUS THERAPEUTICS, INC. (US) 2011-01-27 WO disclosed